| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 53, 120-125, Copyright © 1991 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
G Alfthan, A Aro, H Arvilommi and JK Huttunen
Department of Biochemistry, National Public Health Institute, (Kansanterveyslaitos), Helsinki, Finland.
The mean dietary selenium intake in Finland increased from 40 to 100 micrograms/d in 1987 because of the addition in 1985 of selenium to fertilizers. A selenium-supplementation study was performed in 1987 on the same men as were followed in a 1981 study that had a similar design (200 micrograms Se/d). Selenite and selenate, but not selenium yeast increased platelet glutathione peroxidase (GSHPx) activity by 30% compared with placebo, much less than the 70% found in the previous study. Selenium yeast and selenite increased plasma selenium after 11 wk from 1.39 mumol/L to peak values of 2.15 and 1.58 mumol/L, respectively. Only yeast selenium was incorporated into red cells. From a regression plot based on present and literature data, it was estimated that the plasma selenium concentration needed to achieve maximal platelet GSHPx activity was 1.25-1.45 mumol/L. At the present selenium intake in Finland, 100 micrograms/d, GSHPx activity is saturated in plasma and red cells and almost saturated in platelets.
This article has been cited by other articles:
|
|
 |
|
  A. M Hassan Selenium status in patients with aspirin-induced asthma Ann Clin Biochem, September 1, 2008; 45(5): 508 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P Rayman, A. J Thompson, B. Bekaert, J. Catterick, R. Galassini, E. Hall, M. Warren-Perry, and G. J Beckett Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom Am. J. Clinical Nutrition, February 1, 2008; 87(2): 370 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Karunasinghe, J. Ryan, J. Tuckey, J. Masters, M. Jamieson, L. C. Clarke, J. R. Marshall, and L. R. Ferguson DNA Stability and Serum Selenium Levels in a High-Risk Group for Prostate Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 391 - 397. [Abstract] [Full Text]
|
|
|
|
|
|
D. H. Frank, D. J. Roe, H-H. S. Chow, J. M. Guillen, K. Choquette, D. Gracie, J. Francis, A. Fish, and D. S. Alberts Effects of a High-Selenium Yeast Supplement on Celecoxib Plasma Levels: A Randomized Phase II Trial Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 299 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Mark, Y.-L. Qiao, S. M. Dawsey, Y.-P. Wu, H. Katki, E. W. Gunter, J. F. Fraumeni Jr., W. J. Blot, Z.-W. Dong, and P. R. Taylor Prospective Study of Serum Selenium Levels and Incident Esophageal and Gastric Cancers J Natl Cancer Inst, November 1, 2000; 92(21): 1753 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J Duffield, C. D Thomson, K. E Hill, and S. Williams An estimation of selenium requirements for New Zealanders Am. J. Clinical Nutrition, November 1, 1999; 70(5): 896 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bogye, G. Alfthan, T. Machay, and L. Zubovics Enteral yeast-selenium supplementation in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 225F - 226. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Ortuno, G. Ros, M.J. Periago, C. Martinez, and G. Lopez Biodisponibilidad del selenio y metodos de evaluacion/Selenium bioavailability and methods of evaluation Food Science and Technology International, January 1, 1996; 2(3): 135 - 150. [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
